Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models
Authors:
- 11 September 2002
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (10) , 825-829
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor modelThe Annals of Thoracic Surgery, 2000
- Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral AntigenicityJapanese Journal of Cancer Research, 2000
- Transduction Efficiency of Adenoviral Vectors into Human Glioma Cells Increased by Association with Cationic Liposomes.Neurologia medico-chirurgica, 2000
- Intraarterial Delivery of Adenovirus Vectors and Liposome-DNA Complexes to Experimental Brain NeoplasmsHuman Gene Therapy, 1999
- Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivoGene Therapy, 1998
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997
- Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cellsAtherosclerosis, 1996
- Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of HealthHuman Gene Therapy, 1993